The other major one on the market is tirzepatide, known as Zepbound or Mounjaro
The therapeutic benefit remains stable while the uncomfortable adjustment phase endsa distinction many patients find encouraging as they push through the first few weeks
For example, healthcare systems will need to decide how, when and for what indications they will reimburse new weight-loss drugs
EVIDENCE SECTION: Cite STEP trials, SELECT trial (cardiovascular benefit), professional guidelines (AACE (American Association of Clinical Endocrinology), Endocrine Society), and FDA approval information
However, concerns exist regarding the impact of GLP-1 RAs on lean mass, particularly with respect to true skeletal muscle mass
What works at 0.25 milligrams may not work at 1.0 milligrams or higher